» Articles » PMID: 20848462

Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD

Overview
Specialty Gastroenterology
Date 2010 Sep 18
PMID 20848462
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Few data exist of prospective parallel scoring of the validated endoscopic scores in Crohn's disease (CD), Crohn's Disease Index of Severity (CDEIS), and Simple Endoscopic Score for Crohn's Disease (SES-CD).

Methods: Both the CDEIS and the SES-D were scored immediately after each endoscopy of 86 CD patients referred for ileocolonoscopy in a cross-sectional study. Furthermore, after CD therapy, 32 CD patients underwent a follow-up endoscopy with scoring of the CDEIS and SES-CD. Endoscopic scorings were graded as inactive, mild, moderate, or severe. Clinical activity was assessed with the Crohn's Disease Activity Index (CDAI) and serum C-reactive protein (CRP) was measured.

Results: The SES-CD correlated with the CDEIS significantly (Spearman's r = 0.938, P < 0.0001). Weaker correlations were detected between the SES-CD and the CDAI (r = 0.473) or CRP (r = 0.525, both P < 0.0001). Grading of SES-CD from inactive to severe correlated significantly with grading of the CDEIS (r = 0.859, P < 0.0001). Changes between baseline and follow-up endoscopy scores correlated significantly (r = 0.828 between delta-CDEIS and delta-SES-CD, P < 0.001), but failed to correlate with delta-CDAI or delta-CRP (all P > 0.05).

Conclusions: Both validated endoscopic scores, the CDEIS and SES-CD, and their changes during CD therapy demonstrated a close correlation. For scoring of endoscopic activity in clinical routine, the SES-CD could replace the CDEIS.

Citing Articles

A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease.

Sanderson J, Aboagye J, Makinson R, Rapi K, Provstgaard-Morys S, Stockdale L EBioMedicine. 2025; 113:105570.

PMID: 39922068 PMC: 11848756. DOI: 10.1016/j.ebiom.2025.105570.


A Simple Endoscopic Score for Crohn's Disease (SES-CD) ≥ 7 Predicts Disease Progression.

Peraza J, Kaper M, Bargas A, Kim I, Agrawal M, Larsen L Aliment Pharmacol Ther. 2025; 61(6):1011-1018.

PMID: 39757503 PMC: 11870798. DOI: 10.1111/apt.18492.


Measurements on slope parameter mapping based on dual-energy CT enterography for improving Crohn's disease diagnosis and inflammatory activity evaluation.

Lin Z, Hong M, Zhong H, Zheng X, Lin Y, Yang D Sci Rep. 2025; 15(1):429.

PMID: 39747574 PMC: 11696122. DOI: 10.1038/s41598-024-84705-5.


Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease.

Sands B, Danese S, Chapman J, Gurjar K, Grieve S, Thakur D Inflamm Bowel Dis. 2024; 31(3):857-877.

PMID: 39083264 PMC: 11879194. DOI: 10.1093/ibd/izae159.


Volumetric measurement of terminal ileal Crohn's disease by magnetic resonance enterography: a feasibility study.

Kumar S, Rao N, Bhagwanani A, Parry T, Hameed M, Rahman S Eur Radiol. 2024; 35(1):117-126.

PMID: 39028375 PMC: 11632055. DOI: 10.1007/s00330-024-10880-8.